Search: WFRF:(Ribeiro F.) > (2015-2019) > Transplantation of ...
Fältnamn | Indikatorer | Metadata |
---|---|---|
000 | 04072naa a2200601 4500 | |
001 | oai:gup.ub.gu.se/274255 | |
003 | SwePub | |
008 | 240528s2018 | |||||||||||000 ||eng| | |
024 | 7 | a https://gup.ub.gu.se/publication/2742552 URI |
024 | 7 | a https://doi.org/10.1007/s10875-018-0564-12 DOI |
040 | a (SwePub)gu | |
041 | a eng | |
042 | 9 SwePub | |
072 | 7 | a ref2 swepub-contenttype |
072 | 7 | a art2 swepub-publicationtype |
100 | 1 | a Fernandes, Juliana Folloni4 aut |
245 | 1 0 | a Transplantation of Hematopoietic Stem Cells for Primary Immunodeficiencies in Brazil: Challenges in Treating Rare Diseases in Developing Countries. |
264 | c 2018-11-24 | |
264 | 1 | b Springer Science and Business Media LLC,c 2018 |
520 | a The results of hematopoietic stem cell transplant (HSCT) for primary immunodeficiency diseases (PID) have been improving over time. Unfortunately, developing countries do not experience the same results. This first report of Brazilian experience of HSCT for PID describes the development and results in the field. We included data from transplants in 221 patients, performed at 11 centers which participated in the Brazilian collaborative group, from July 1990 to December 2015. The majority of transplants were concentrated in one center (n=123). The median age at HSCT was 22months, and the most common diseases were severe combined immunodeficiency (SCID) (n=67) and Wiskott-Aldrich syndrome (WAS) (n=67). Only 15 patients received unconditioned transplants. Cumulative incidence of GVHD grades II to IV was 23%, and GVHD grades III to IV was 10%. The 5-year overall survival was 71.6%. WAS patients had better survival compared to other diseases. Most deaths (n=53) occurred in the first year after transplantation mainly due to infection (55%) and GVHD (13%). Although transplant for PID patients in Brazil has evolved since its beginning, we still face some challenges like delayed diagnosis and referral, severe infections before transplant, a limited number of transplant centers with expertise, and resources for more advanced techniques. Measures like newborn screening for SCID may hasten the diagnosis and ameliorate patients' conditions at the moment of transplant. | |
650 | 7 | a MEDICIN OCH HÄLSOVETENSKAPx Klinisk medicinx Pediatrik0 (SwePub)302212 hsv//swe |
650 | 7 | a MEDICAL AND HEALTH SCIENCESx Clinical Medicinex Pediatrics0 (SwePub)302212 hsv//eng |
700 | 1 | a Nichele, Samantha4 aut |
700 | 1 | a Daudt, Liane E4 aut |
700 | 1 | a Tavares, Rita B4 aut |
700 | 1 | a Seber, Adriana4 aut |
700 | 1 | a Kerbauy, Fábio R4 aut |
700 | 1 | a Koliski, Adriana4 aut |
700 | 1 | a Loth, Gisele4 aut |
700 | 1 | a Vieira, Ana K4 aut |
700 | 1 | a Darrigo-Junior, Luiz G4 aut |
700 | 1 | a Rocha, Vanderson4 aut |
700 | 1 | a Gomes, Alessandra A4 aut |
700 | 1 | a Colturato, Vergílio4 aut |
700 | 1 | a Mantovani, Luiz F4 aut |
700 | 1 | a Ribeiro, Andreza F4 aut |
700 | 1 | a Ribeiro, Lisandro L4 aut |
700 | 1 | a Kuwahara, Cilmara4 aut |
700 | 1 | a Rodrigues, Ana L M4 aut |
700 | 1 | a Zecchin, Victor G4 aut |
700 | 1 | a Costa-Carvalho, Beatriz T4 aut |
700 | 1 | a Carneiro-Sampaio, Magda4 aut |
700 | 1 | a Condino-Neto, Antonio4 aut |
700 | 1 | a Fasth, Anders,d 1945u Gothenburg University,Göteborgs universitet,Institutionen för kliniska vetenskaper, Avdelningen för pediatrik,Institute of Clinical Sciences, Department of Pediatrics4 aut0 (Swepub:gu)xfasan |
700 | 1 | a Gennery, Andrew4 aut |
700 | 1 | a Pasquini, Ricardo4 aut |
700 | 1 | a Hamerschlak, Nelson4 aut |
700 | 1 | a Bonfim, Carmem4 aut |
710 | 2 | a Göteborgs universitetb Institutionen för kliniska vetenskaper, Avdelningen för pediatrik4 org |
773 | 0 | t Journal of clinical immunologyd : Springer Science and Business Media LLCg 38:8, s. 917-926q 38:8<917-926x 1573-2592x 0271-9142 |
856 | 4 | u https://lume.ufrgs.br/bitstream/10183/204336/1/001107016.pdf |
856 | 4 8 | u https://gup.ub.gu.se/publication/274255 |
856 | 4 8 | u https://doi.org/10.1007/s10875-018-0564-1 |
Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.